Fig. 9

Molecular docking with binding energy ≤ -10 kcal/mol. (A) PRKACA(3ovv) with (S)-Stylopine. (B) PRKACA(3ovv) with Stigmasterol. (C) PTGS2(5f19) with (S)-Stylopine. (D) PTGS2(5f19) with Stigmasterol. (E) NR3C1(4udd) with (S)-Stylopine
Molecular docking with binding energy ≤ -10 kcal/mol. (A) PRKACA(3ovv) with (S)-Stylopine. (B) PRKACA(3ovv) with Stigmasterol. (C) PTGS2(5f19) with (S)-Stylopine. (D) PTGS2(5f19) with Stigmasterol. (E) NR3C1(4udd) with (S)-Stylopine